Skip to content
Screener

DBV Technologies DBVT Total Operating Expenses

Total Operating Expenses at other companies

Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$57.25M-24.5%
Alumis Inc. logo
Alumis Inc.ALMS
$100.15M-15.8%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$140.61M+46.4%

Segments

By segment

See full
VIASKIN® Peanut$51.3M+20.4%

By product

See full
Expenses by function$18M+83.7%

Other financials

Income statement

See full
Revenue$700.0K-53.3%
Operating income-$50.6M-23.1%
Net income-$50.4M-20.3%
EPS (diluted)-$0.12+61.3%

Balance sheet

See full
Cash & equivalents$174.9M+69.5%
Total debt$7.7M+0.1%
Total equity$160.4M+86.1%
Total assets$223.2M+55.6%

Cash flow

See full
Operating cash flow-$52.6M-55.2%
CapEx$400.0K
Free cash flow-$53.0M-56.3%

Valuation

See full
Market cap$847.16M+218%
Enterprise value$679.96M+297%
P/S168.8×+100×

Profitability

See full
Operating margin-3,543.1%+523pp
Net margin-3,506.5%+442pp
FCF margin-3,399.3%+3,268pp

Returns & leverage

See full
Return on equity-142.7%-5.0pp
Debt / equity0.0×
Current ratio3.7×+1.3×

Where this comes from

Reported directly by DBV Technologies in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The source filing: DBV Technologies’s 10-Q, filed July 16, 2026.

Filed
Jul 16, 2026, 4:08 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-048453
Line itemNoteThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Research and development expenses(31.2)(33.7)(64.6)(55.2)
Sales and marketing expenses(5.5)(0.4)(10.4)(0.7)
General and administrative expenses(14.6)(8.5)(25.1)(14.1)
Total Operating expenses(51.3)(42.6)(100.1)(69.9)
Loss from operations(50.6)(41.1)(98.5)(67.7)
Financial income (expense)0.4(0.6)0.9(1.1)
Loss before taxes(50.2)(41.8)(97.6)(68.8)
Income tax(0.2)(0.1)(0.4)(0.1)

Item 1C. Condensed Consolidated Statements of Financial Position (Unaudited) as of

FAQ

What is DBV Technologies's total operating expenses?
DBV Technologies (DBVT) reported total operating expenses of $51.3M in Q2 2026.
How has DBV Technologies's total operating expenses changed year-over-year?
DBV Technologies's total operating expenses increased by 20.4% year-over-year, from $42.6M to $51.3M.
What is the long-term trend for DBV Technologies's total operating expenses?
Over 4 years (2021 to 2025), DBV Technologies's total operating expenses has grown at a 10.0% compound annual growth rate (CAGR), from $104.32M to $152.75M.
What does total operating expenses mean?
The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.

Ask your AI about DBV Technologies's total operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude